Product
SOV2012-F1
2 clinical trials
2 indications
Indication
HypogonadismIndication
maleClinical trial
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)Status: Completed, Estimated PCD: 2020-05-01
Clinical trial
A 6 Month, Open Label, Ambulatory Blood Pressure Monitoring (ABPM) Extension StudyStatus: Completed, Estimated PCD: 2020-05-01